Therefore, the regulation of non-coding RNA aroused our interest, and we hypothesized that overexpression of MAP3K3 in ovarian carcinoma may be related to gene amplification, RAS gene mutation, and the regulation of epigenetics. Here, MAP3K3 is linked to ovarian carcinoma.